Ligand Enters Commercial License and Supply Agreements with Marinus Pharmaceuticals for Captisol-Enabled Ganaxolone April 5, 2017
Ligand Announces Licensing Partner Janssen Has Filed an IND for an Antibody Discovered Using the OmniAb® Technology March 28, 2017
Ligand Expands License with Sermonix to Include Worldwide Rights for Oral Lasofoxifene February 28, 2017
Dr. Christel Iffland Joins Ligand as Vice President, Antibody Technologies, Expands Team Focused on OmniAb Drug Discovery Platform February 14, 2017
